mortality/aging
• survival rate decreased after E10
• surviving embryos have normal lifespan
|
Allele Symbol Allele Name Allele ID |
Stard7tm1a(EUCOMM)Wtsi targeted mutation 1a, Wellcome Trust Sanger Institute MGI:4433666 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• survival rate decreased after E10
• surviving embryos have normal lifespan
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• after sensitization by i.p. injection of OVA on days 0 and 7, followed by intratracheal challenge with OVA on days 18-21
|
• increased epithelial barrier permeability
|
N |
• after sensitization and challenge with OVA
|
• in lung and lung-draining lymph nodes
|
• skin lesions, mainly on ears and back
• vigorous scratching
|
N |
• from 6-7 months after sensitization and challenge with OVA
|
• skin lesions, mainly on ears and back
• vigorous scratching
|
• in skin lesions
|
N |
• after sensitization and challenge with OVA
|
• in lung and lung-draining lymph nodes
|
• pulmonary mucous cell metaplasia after sensitization and challenge with OVA
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|